Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s proprietary technology platforms specialize in ODT, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.
To learn more, please visit us at www.AdarePharma.com
With Orbis Biosciences acquisition Adare has now 3 technologies for taste-masked and controlled release multi-particulates. The technologies allow creation of sustained release oral suspensions and injectables.